5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione
C106H81F3N18O15S2 — CID 158375972
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione
5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione (PubChem CID 158375972) has the molecular formula C106H81F3N18O15S2 and a molecular weight of 1968.05 g/mol. Its IUPAC name is 5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione.
Molecular Properties
| Compound Name | 5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione |
|---|---|
| PubChem CID | 158375972 |
| Molecular Formula | C106H81F3N18O15S2 |
| Molecular Weight | 1968.05 g/mol |
| Exact Mass | 1966.55 |
| IUPAC Name | 5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(4-imidazol-1-ylphenyl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5S)-5-[(5-fluoro-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(3-oxo-4H-1,4-benzothiazin-8-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1H-indazol-5-yl)phenyl]imidazolidine-2,4-dione |
| SMILES | COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5[nH]ncc5c4)cc3)NC(=O)NC1=O)C2.O=C1CSc2c(cccc2-c2ccc([C@@]3(CN4Cc5ccc(F)cc5C4=O)NC(=O)NC3=O)cc2)N1.O=C1CSc2c(cccc2-c2ccc([C@]3(CN4Cc5ccc(F)cc5C4=O)NC(=O)NC3=O)cc2)N1.O=C1NC(=O)C(CN2Cc3ccc(F)cc3C2=O)(c2ccc(-c3ccc(-n4ccnc4)cc3)cc2)N1 |
| InChI | InChI=1S/C27H20FN5O3.C27H23N5O4.2C26H19FN4O4S/c28-21-8-3-19-14-33(24(34)23(19)13-21)15-27(25(35)30-26(36)31-27)20-6-1-17(2-7-20)18-4-9-22(10-5-18)32-12-11-29-16-32;1-15-9-18(10-19-12-28-31-23(15)19)16-3-6-20(7-4-16)27(25(34)29-26(35)30-27)14-32-13-17-5-8-21(36-2)11-22(17)24(32)33;2*27-17-9-6-15-11-31(23(33)19(15)10-17)13-26(24(34)29-25(35)30-26)16-7-4-14(5-8-16)18-2-1-3-20-22(18)36-12-21(32)28-20/h1-13,16H,14-15H2,(H2,30,31,35,36);3-12H,13-14H2,1-2H3,(H,28,31)(H2,29,30,34,35);2*1-10H,11-13H2,(H,28,32)(H2,29,30,34,35)/t;27-;2*26-/m.010/s1 |
| InChIKey | GVESNGBKVMRBAG-RBUKCGJUSA-N |
| XLogP | 13.06 |
| TPSA | 427.97 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 144 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1968.05 |
| LogP ≤ 5 | 13.06 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 20 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158375972 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.